Introduction
Nucleotide-excision repair (NER) is a complex repair pathway able to detect and remove a variety of bulky DNA lesions such as UVBinduced photoproducts from the genome of many organisms (Lindahl & Wood, 1999; Araujo & Wood, 1999) . NER in eukarya involves the coordinated recruitment of a large number of proteins to recognize, unravel and excise a short oligonucleotide bearing the DNA lesion prior to ®lling in the missing gap (Araujo & Wood, 1999) . The two unrelated endonucleases XPF and XPG selectively cleave the damaged DNA strand either side of the lesion and this is facilitated by their different respective substrate polarities (Petit & Sancar, 1999) . XPF endonucleases recognize and cleave double-strand/single-strand DNA junctions with a single-stranded 3 H overhang, whilst XPG prefers similar substrates but with 5 H overhangs (Sijbers et al., 1996; de Laat et al., 1998; Hohl et al., 2003) .
XPF endonucleases are found in both eukaryotes and archaea (Sgouros et al., 1999; White, 2003) . They have an endonuclease domain followed by two consecutive helix± hairpin±helix motifs that form an (HhH) 2 domain (Nishino et al., 2003; Doherty et al., 1996) . The endonuclease domain contains the catalytic motif GDX n ERKX 3 D related to type II endonucleases, while the (HhH) 2 domain has been shown to mediate dimerization and to exhibit a sequence-independent DNA-binding function (Nishino et al., 2003; Shao & Grishin, 2000) . Eukaryotic XPFs have an SF2-like helicase domain at the amino-terminus that apparently lacks essential catalytic residues for ATPase activity (Sgouros et al., 1999) . A similar`long' form of XPF is present in most euryarchaea, although notably their respective helicase domains are predicted to exhibit ATPase activity (White, 2003; Sgouros et al., 1999; Komori et al., 2002) . Crenarchaea have à short' form of XPF that lacks a helicase-like domain and whose catalytic activity is regulated by interaction with PCNA (Roberts et al., 2003) . All XPFs studied require divalent cations for nuclease activity and can form either heterodimers (eukaryotic) with a shorter but structurally related binding partner or homodimers (archaea) (Sijbers et al., 1996; Nishino et al., 2003) .
To investigate XPF architecture and the basis for substrate recognition, we initiated structural studies on a short XPF from Aeropyrum pernix (apXPF) that is 254 residues long (predicted molecular weight 28 726 Da). Here, we report the crystallization of three different crystal forms of apXPF from two truncated gene products corresponding to residues 19± 231 (apXPF-ÁNÁC) and residues 19±150 (apXPF-ÁHhH 2 ). One crystal form was grown in the presence of double-stranded DNA to mimic an enzyme±product complex.
Expression and purification of apXPF
The gene encoding A. pernix XPF (accession codes C72622 and APE1043) was ampli®ed from a plasmid generated from the A. pernix genome sequencing project (see http:// www.bio.nite.go.jp:8080/dogan). Synthetic oligonucleotide primers were designed to remove regions of the protein that we anticipated to bē exible and that could hinder crystallization. The forward primer was 5 H -TATAGGATCC-GGGTGGTCGTCCGCGTGTTTATGTGGA-TGTTAGGGAGGAG and the reverse primer was 5 H -TATAGGATCCCTATTATTAGCTA-CGCTTGTAAGGTGTCATGAGTATCTT. This deleted the C-terminal 23 residues that comprise the PCNA-binding motif and the N-terminal 18 residues (and will be referred to subsequently as apXPF-ÁNÁC). The oligonucleotides introduced a BamH1 restriction site at either side of the ampli®ed gene to allow subcloning into a modi®ed expression vector (designated pET-14b-3C). This vector was derived from the pET-14b (Novagen) vector and altered to incorporate a 3C precision protease-cleavage site between the histidine tag and the cloned gene. This vector was transformed into Rosetta (DE3) pLysS bacterial cells (Novagen) for expression purposes.
A shorter construct was designed with a similar strategy and eliminated the (HhH) 2 domain (leaving residues 19±150, which we de®ne as apXPF-ÁHhH 2 ). The oligonucleotide primers were 5
H -TATAGGATC-CGGGTGGTCGTCCGCGTGTTTATGT-GGATGTTAGGGAGGAG (forward primer) and 5
H -TATAGGATCCCTATTA-TTACTCTCTAGTGGAGAGGCGGGCG-AGGCT (reverse primer). DNA sequencing con®rmed that the correct sequence was obtained by PCR.
Both apXPF-ÁNÁC and apXPF-ÁHhH 2 proteins were expressed by induction with 0.5 mM IPTG overnight at 303 K when the Rosetta(DE3) pLysS cells reached an OD of 0.6. The apXPF-ÁNÁC protein was extracted following sonication of the cell pellets using a buffer comprised of 20 mM Tris±HCl pH 8.0, 0.5 M NaCl, 2 mM 2-mercaptoethanol (buffer A) and containing 5 mM imidazole, 1 mM PMSF, 10 mM benzamidine and 0.1 mg ml À1 DNAse. Clari®ed supernatant was mixed with Ni±NTA resin washed extensively in buffer A containing 20 mM imidazole. The polyhistidine-tagged apXPF-ÁNÁC was eluted with buffer A containing 0.5 M imidazole by pelleting the Ni±NTA resin for 2 min at 500g. The eluted protein was then dialysed overnight against buffer A. The polyhistidine tag was eliminated by addition of 100 mg of 3C protease per 10 mg recombinant protein at 277 K overnight, followed by the addition of a small amount of Ni± NTA agarose to remove the tag and uncleaved protein. Puri®ed protein was then concentrated to approximately 4 mg ml À1 using Centriprep10 (Amicon Corporation) prior to crystallization. Recombinant apXPF-ÁHhH 2 protein was extracted and puri®ed in an identical manner to the longer construct except that all buffers included 0.5%(w/v) CHAPS (Sigma). The detergent was needed in order to ef®ciently elute the protein from the Ni±NTA resin. Both recombinant apXPF-ÁNÁC and apXPFÁHhH 2 proteins were biosynthetically labelled with selenomethionine using the methionine-auxotrophic bacterial strain B834 (Novagen). These cells were transformed with either of the pET14b-apXPF constructs together with the Rosetta pLysS plasmid and were grown in minimal media supplemented with selenomethionine using standard techniques (Doublie Â, 1997) .
Following Ni±NTA agarose puri®cation, native and selenomethionine-labelled apXPF-ÁNÁC proteins were further puri®ed by a single-stranded DNA (ssDNA) agarose column and size-exclusion chromatography using an identical protocol. The ssDNA af®nity column was prepared using denatured calf thymus DNA agarose according to the manufacturers' instructions (Amersham-Pharmacia).
The apXPF-ÁNÁC protein was dialysed into 20 mM Tris pH 8.0, 0.05 M NaCl and loaded onto the af®nity column. A linear gradient of 0.05± 1 M NaCl was applied using an A È KTA FPLC system. The bound protein eluted as a single peak at 0.6 M NaCl. This sample was then loaded onto a Pharmacia Superdex 75 column pre-equilibrated in 20 mM Tris pH 8.0, 0.5 M NaCl, 1 mM DTT. Native apXPF-ÁNÁC has a predicted molecular weight of 25 097 Da. Both native and selenomethionine-labelled apXPF-ÁNÁC proteins both migrated with an apparent molecular weight of 42 kDa, indicating that they are associated as dimers. We then conducted static light-scattering experiments on puri®ed native apXPF-ÁNÁC proteins at 0.5 mg ml À1 in 20 mM Tris pH 8.0, 0.5 M NaCl, 1 mM DTT using a MiniDawn Instrument (Wyatt Technologies). These experiments showed that the protein was monodisperse and solving the Zimm equation (Wilson, 2003) gave an approximate molecular weight of 51.6 AE 0.5 kDa, indicating a dimer. Puri®ed native and selenomethionine-labelled apXPF-ÁHhH 2 was also dimeric as judged by size-exclusion chromatography under similar buffer conditions [except for the inclusion of 0.5%(w/v) CHAPS in the buffer]. These data are consistent with studies on the related`long' XPF from Pyrococcus furiosus, which was shown to be dimeric (Nishino et al., 2003) . This may be a more general property of archaeal XPFs and contrasts with the heterodimeric state eukaryotic XPF complexes (White, 2003) .
Crystallization
Puri®ed apXPF-ÁNÁC was concentrated to 7 mg ml À1 in 20 mM Tris±HCl pH 8.0, 0.5 M NaCl, 10 mM NDSB201 (Calbiochem) prior to crystallization. Needle-shaped crystals (Fig. 1 ) grew in 65%(v/v) MPD, 0.1 M Tris± HCl pH 8.0 and pH 9.0 in sitting drops and appeared after 6±10 weeks. Crystals of apXPF-ÁNÁC labelled with selenomethionine were also grown under similar conditions; however, their diffraction properties were very poor (typically $8±10 A Ê resolution) and they were not pursued further. To crystallize apXPF-ÁNÁC with dsDNA to mimic an enzyme±product complex, we prepared a series of different length duplex DNA ranging from 11 to 17 base pairs using complementary HPLC-puri®ed oligonucleotides. These were mixed with 10 mg ml solution. The best quality crystals grew using a 15-mer dsDNA with sequence TCAG-CATCTGTGATC annealed to a complementary oligonucleotide. These barrelshaped crystals (Fig. 1 ) grew in Hampton Crystal Screen II condition No. 13 [0.1 M sodium acetate, 0.2 M ammonium sulfate, 20%(w/v) PEG MME 2K] by the vapourdiffusion method using hanging drops at room temperature. Crystals took at least six weeks to grow. Similar crystals of selenomethionyl-labelled apXPF-ÁNÁC were grown in the presence of dsDNA but gave little or no diffraction and were not pursued further.
Native and selenomethionine-labelled apXPF-ÁHhH 2 proteins were concentrated to 3 mg ml À1 in 20 mM Tris pH 8.0, 0.5 M NaCl, 0.5%(w/v) CHAPS for crystallization. Crystals of both forms of apXPF-ÁHhH 2 were grown in 10%(w/v) PEG 400, 0.05 M sodium acetate pH 5.0 by mixing protein: well solution in a 1:1 ratio under mineral oil in hydrophobic vapour batch trays (Douglas Instruments). Crystals of native and selenomethionine-labelled proteins grew in a few days and were prepared using a Douglas Instruments IMPAX I-5 crystallization robot with 2 ml drops.
X-ray analysis
For data collection, the trigonal and triclinic crystals were transferred into Paratone-N (Hampton) for 1±2 min and then¯ash-cooled in a nitrogen stream at 120 K from an Oxford Instruments Cryostream. The monoclinic crystals of apXPF-ÁNÁC werē ash-cooled directly from the drop, as the concentration of MPD used as precipitant was suf®ciently high to act as a cryoprotectant. Data were collected on either station 9.6 at the SRS synchrotron source, Daresbury or on beamline BM14 at the ESRF, Grenoble. Data were processed and integrated using either HKL or MOSFLM dataprocessing software (Collaborative Computational Project, Number 4, 1994; Otwinowski & Minor, 1997) and space-group assignments were made based on autoindexing solutions and consideration of systematic lattice absences. Data to 2.8 A Ê were measured from trigonal crystals of native apXPF-ÁNÁC grown in the presence of dsDNA. These crystals belong to space group P3 1 21 or P3 2 21 (Table 1) . Monoclinic crystals of native apXPF-ÁNÁC belong to space group C2 and have a diffraction limit of 3.2 A Ê ( Table 1) . Crystals of apXPFÁHhH 2 were triclinic and therefore belong to space group P1. Although crystals of the native protein diffract to 2.1 A Ê , at this time we have only measured data to 2.5 A Ê for crystals of selenomethionine-labelled apXPF-ÁHhH 2 .
To identify non-crystallographic twofold axes in each of the crystal forms, we inspected the 1 = 180 section of a selfrotation function calculated using MOLREP (Vagin & Teplyakov, 2000) . Using data from the triclinic crystals of apXPF-ÁHhH 2 , a single non-crystallographic twofold axis at ( = 90, 9 = 0, 1 = 180 ) was evident with a peak height of 14.71' parallel to a. This agrees with solvent calculations, which suggested a dimer in the asymmetric unit with a solvent content of 34.5%. Selfrotation function analysis for the monoclinic crystals of apXPF-ÁNÁC also revealed a non-crystallographic twofold axis at ( = 28, 9 = 0, 1 = 180 ) perpendicular to b with a peak height of 7'. In this crystal form the asymmetric unit contents are less clear, as either one dimer (solvent content 71.7%) or two dimers (solvent content 43.4%) per asymmetric unit are feasible. The trigonal apXPF-ÁNÁC-dsDNA crystals may contain one dimer (solvent content 77.3%) or two dimers (solvent content 54.6%) in the asymmetric unit. However, we found no evidence of a non-crystallographic twofold axis over a range of resolution cutoffs and Patterson integration radii.
Discussion
The XPF gene has been cloned from A. pernix and expressed in a bacterial host to produce suf®cient quantities of recombinant protein to initiate a structural analysis. Puri®ed apXPF binds tightly to an ssDNA af®nity column and we show from gel®ltration and light-scattering experiments that it is dimeric in solution. We report here three crystal forms of apXPF that diffract to moderate resolution at a synchrotron source. A self-rotation analysis of the trigonal crystal form showed no evidence of a non-crystallographic twofold. However, in high-symmetry space groups it is frequently observed that non-crystallographic and crystallographic symmetries coincide, therefore effectively masking the presence of the former. In contrast, self-rotation searches on the monoclinic and triclinic crystal forms showed clear evidence of a non-crystallographic twofold axis consistent with the solution data.
To obtain phasing information, we prepared crystals of selenomethioninelabelled protein. However, this phasing strategy was hindered by the lack of diffraction from crystals of selenomethionine-labelled apXPF-ÁNÁC. We therefore puri®ed and crystallized a shorter form of apXPF lacking the (HhH) 2 domain. Crystals of selenomethionine-labelled apXPFÁHhH 2 diffract as well as native apXPFÁHhH 2 crystals and should provide experimental phasing for the endonuclease domain. While this work was being undertaken, the structure of the Hef/pfXPF nuclease domain was determined (Nishino et al., 2003) . The availability of these coordinates (50% identity to apXPF) gives an alternative route to phasing data from apXPF-ÁHhH 2 crystals by molecular replacement. An apXPF endonuclease domain structure will provide a partial model to phase data from crystals of apXPF-ÁNÁC. Although molecular-replacement search models are available for the apXPF (HhH) 2 domain, these are quite divergent in both sequence and structure (Shao & Grishin, 2000) . The closest to apXPF is the UvrC (HhH) 2 domain, which is only 30% identical and was determined by NMR (Singh et al., 2002) . We therefore intend to supplement phasing information for the apXPF-ÁNÁC crystals by screening heavyatom derivatives and/or using iodinated oligonucleotides. The crystals described here provide an opportunity to determine the ®rst structure of a full-length XPF and to understand how XPF recognizes and cleaves ds-ssDNA junction substrates.
